| scholarly article | Q13442814 |
| P2093 | author name string | R J Orentas | |
| L A Bircher | |||
| S Roskopf | |||
| P2860 | cites work | SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat | Q29620254 |
| Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes | Q33811112 | ||
| Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction | Q34354588 | ||
| The complete 685-kilobase DNA sequence of the human beta T cell receptor locus | Q34382665 | ||
| Potential antigenic targets on Epstein-Barr virus-associated tumours and the host response. | Q40553820 | ||
| CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells | Q40872749 | ||
| Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors | Q41035522 | ||
| Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. | Q41180520 | ||
| Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance | Q41258361 | ||
| Cytotoxic activity of human lymphocytes: quanitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics | Q41296430 | ||
| Genetic modification of T-cell clones for therapy of human viral and malignant diseases. | Q43696495 | ||
| Differential recognition and lysis of EL4 target cells by cytotoxic T cells: differences in H-2Kb antigenic density and cytoskeletal proteins. | Q43980453 | ||
| Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: lytic parameters and evaluation of cellular inhibition | Q44666708 | ||
| Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide | Q45738922 | ||
| Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes | Q45771097 | ||
| Activated lymphocytes during acute Epstein-Barr virus infection | Q45833905 | ||
| T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
| Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones | Q67518698 | ||
| Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression | Q67687100 | ||
| Kinetic analysis of human IL-2 activated cytotoxic cells | Q67822289 | ||
| Kinetic analysis of cloned cytotoxic T lymphocyte reactivity against normal and leukaemic target cells | Q68814718 | ||
| Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity | Q77929305 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 33-42 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Scandinavian Journal of Immunology | Q15762682 |
| P1476 | title | Retroviral transfer of T-cell receptor genes produces cells with a broad range of lytic activity | |
| P478 | volume | 58 |
| Q33841127 | A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection |
| Q36011784 | Exploiting T cell receptor genes for cancer immunotherapy |
| Q34506910 | Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer |
| Q34008900 | Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication |
| Q40328361 | Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: A novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma |
Search more.